Daniel Penrice

GI Fellow @MayoClinicGIHep via @MayoMN_IMRES & @UNMC | Interests: Hepatology, Remote Patient Monitoring, Telomere Biology Disorders

[Gianrico Farrugia @GFarrugiaMD]

Researchers at Mayo Clinic studied early outcomes of a remote patient monitoring program for patients with decompensated cirrhosis. Results showed high satisfaction and may potentially lead to reduced hospital readmissions and decreased morbidity: https://t.co/ffpyo9hcTH

[Elliot Tapper @ebtapper]

Monitoring patient reported outcomes with virtual monitoring by nurses might reduce readmissions and patients love it

Congratulations to @DanielDPenrice on this paper in @HepCommJournal

https://t.co/Hqlu1GvMuD

[American Gastroenterological Association (AGA) @AmerGastroAssn]

Now entering a new frontier: #artificialintelligence in science. #SmallTalkBigTopics’ @MJWhitsonMD chats with @renumathyd, @DanielDPenrice and @alystraussMD about what #AI means for #GI. Listen now:

🎧 Apple: https://t.co/FXrOXvrZ6h
🎧 Spotify: https://t.co/kmCCMzPlgs

[Brian Sutterer MD @BrianSuttererMD]

The world lost an amazing friend, husband, doctor, and young father to be this week. Mick was a friend to everyone who met him and could always put a smile on your face. I was blessed to call him a friend and may he rest in peace.

Sharing this fund for any of his other friends and colleagues wondering how they can provide support during this tragic time

https://t.co/mOvtlFTSRV

[Doug Simonetto, MD @DougSimonetto]

Celebrating our incredible team with tapas and an early morning run! #LiverRun #LiverLoop #TLM22

@MayoClinicGIHep @DanielDPenrice @Puru_MD @TiffanyWuMD @JosephCAhnMD @TejasavSehrawat

[Daniel Penrice @DanielDPenrice]

@sordicharaMD @DougSimonetto @GallodeMoraesMD @ACPinternists @mn_acp Amazing!! Great job Beatriz!

[Daniel Penrice @DanielDPenrice]

@HaraKamalpreet @AmCollegeGastro @VictorChedidMD @DougSimonetto @AmritKambojMD @dunleavy_katie Great work @HaraKamalpreet !!!

[Daniel Penrice @DanielDPenrice]

@dunleavy_katie @AKBrews @LJanssensMD @KhushbooSGala I believe this is the conference hotel for Belgian Week of GI

[Liver International @LiverInt]

Differences in presentation & outcomes in patients with liver nodular regenerative hyperplasia:

❗ Usually considered a benign condition
❗ But significant morbidity if portal hypertension is present

📝 https://t.co/zHUg9dR2CO

✍️ @DanielDPenrice @DougSimonetto

#LiverTwitter

[Elliot Tapper @ebtapper]

Nodular regenerative hyperplasia can be very confusing

I enjoyed learning more about NRH from @DanielDPenrice and @DougSimonetto

https://t.co/tGsVfIwwbN

Some take homes in paper:
1️⃣age is key driver of outcomes
2️⃣cause of nrh less important
#livertwitter

[Tiffany Wu, MD MS @TiffanyWuMD]

Excited to share our review on "The Digital Transformation of Hepatology: The Patient is Logged In" ➡️ featured on the cover of Hepatology this March! 😃

I'm so thankful for the guidance and expertise from @Dr_Vijay_Shah @DougSimonetto @jhalamka 💫✨

https://t.co/BxpbMfa2C9

[Naveen Reddy @DrReddyGI]

Good primer on key concepts in #ArtificialIntelligence and #MachineLearning in @AGA_GHAdvances by @Puru_MD, @DanielDPenrice, & @DougSimonetto

#GITwitter #AI #livertwitter

https://t.co/dW4IBu63jw

[Puru Rattan, MD @Puru_MD]

Honored and proud to present our primer on Machine Learning and #AI in Medicine in the first issue of @AGA_GHAdvances. @DanielDPenrice @DougSimonetto

[Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep]

#ScholarlySunday-Telomere Biology Disorder: TBD, a genetically inherited syndrome resulting in premature telomere shortening & can lead to cirrhosis Pts w/ severe complications can be considered for transplant https://t.co/EH6NqcW7on @DanielDPenrice @DougSimonetto @JHepatology

[Puru Rattan, MD @Puru_MD]

Can a score based on an EKG predict outcomes in liver disease?? Excellent oral presentation by @JosephCAhnMD just introduced that possibility at Parallel 25: Portal Hypertension Clinical @AASLDtweets #TLMdX #LiverMtg21 moderated by @singal_ashwani @AtoosaRabiee

[Journal of Hepatology @JHepatology]

Worldwide study:

Corticosteroids improve 30-day survival among patients with severe alcohol-associated #hepatitis, especially with MELD scores between 25 and 39

By @juanpabloarab & @LuisAntonioDiaz & colleagues➡️https://t.co/EafGtK3FOk

[Hepatology Communications @HepCommJournal]

Alcohol-Induced Liver Injury: Down-regulation and Redistribution of Rab3D Results in Atypical Protein Trafficking

https://t.co/kAxTp4gQmr

#alcoholliverdisease #livertwitter #VisualAbstract #openaccess @armpetr

[Puru Rattan, MD @Puru_MD]

Very excited to share some of the liver disease and #telomeres research we have been doing at @MayoClinicGIHep

⬇️ TL assoc. w/ ⬆️ fibrosis in older ages
⬇️ TL ➕ all-cause mortality is 📈 in:
🧬Liver Disease
🧬Women
🧬Non-White Race/Ethnicity

https://t.co/dt92lO65u2

[Daniel Penrice @DanielDPenrice]

Check out our new publication on predicting infection in Alcohol-Associated Hepatitis! @HepCommJournal

Be on the lookout for infection if:
⬆️ MELD Score
⬆️ WBC Count
🚰 Ascites present at admission
💊 Corticosteroid Administration

Link: https://t.co/mc7MdFGrRZ

[Elliot Tapper @ebtapper]

#livertwitter stop what you are doing and read @nejm

CONFIRM
ATTIRE
And an editorial from @ggarciatsao